Verbatim response from Claude
Wegovy vs Zepbound: Quick Comparison
The Drugs
Wegovy (semaglutide)
- GLP-1 receptor agonist
- ~15% average body weight loss in trials
- Made by Novo Nordisk
- Weekly injection
Zepbound (tirzepatide)
- Dual GIP/GLP-1 receptor agonist
- ~20-22% average body weight loss in trials
- Made by Eli Lilly
- Weekly injection
Which to Ask For?
Zepbound has the edge for most people because:
- Stronger average weight loss in head-to-head data
- Often more affordable with Lilly's savings card (~$550/month or less with insurance)
- Newer but well-studied
Consider Wegovy if:
- You have cardiovascular disease (it has an FDA-approved CV benefit indication)
- Your insurance covers it but not Zepbound
Where to Get Either Online
- Hims & Hers – easy telehealth access, though often offers compounded versions
- Ro Body – straightforward process, good support
- Lilly Direct – gets you actual branded Zepbound directly
- Found or Calibrate – include coaching programs
⚠️ Important Notes
- Require a prescription from a licensed provider
- Avoid unverified online pharmacies selling compounded versions without oversight
Talk to your doctor about your specific health history first!